Biotech Series B Investors & VC Firms
725 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.
Shinhan Venture Investment
SeoulSeries A–Series B
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
BDC Climate Tech Fund II
MontréalSeed–Growth
Ikarian Capital
DallasSeries A–Late Stage
Nissay Capital
TokyoPre-Seed–Growth
1 person
Oikos Ventures
MontevideoSeed–Growth
1 person
Aflac Ventures Japan
TokyoSeed–Growth
7 people
EMBRAPII
BrasíliaPre-Seed–Growth
Hefei High-tech VC
HefeiSeed–Series C
Seoul Investment Partners
SeoulSeed–Late Stage
Stonebridge Ventures
SeoulSeries A–Series C
3 people
The Wells Investment
SeoulSeed–Late Stage
Egora Holding
MartinsriedSeed–Series B$5.4M
GERBER-RAUTH
MilanPre-Seed–Late Stage
CIBC
TorontoPre-Seed–Late Stage$1.5M – $29.2M
1 person
Action Potential Venture Capital Ltd.
Scotts ValleySeed–Late Stage
3 people
ePlanet Capital
San JoseSeed–Late Stage
3 people
IMM Investment
KangnamPre-Seed–Growth
GBS Venture Partners Ltd.
MelbourneSeed–Growth$165K – $7.9M
2 people
CDF-Capital
ShenzhenSeed–Late Stage
Hiroshima Innovation Network
HiroshimaPre-Seed–Growth
K2 Global
WilmingtonPre-Seed–Series C
3 people
Laval Innov
LavalPre-Seed–Late Stage
NATO Innovation Fund
AmsterdamSeed–Series B$16.2M
3 people
Related lists
Series B Investors & VC Firms (2956)Biotech Investors & VC Firms (2489)Biotech Seed Investors & VC Firms (2031)Series B Investors & VC Firms in North America (1738)Biotech Series A Investors & VC Firms (1629)Biotech Investors & VC Firms in North America (1606)Series B Investors & VC Firms in United States (1573)Biotech Investors & VC Firms in United States (1455)SaaS Series B Investors & VC Firms (1077)Series B Investors & VC Firms in Europe (1073)
Data sourced from public filings and firms' own websites — see our methodology.






